International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: Report from the 13th International Congress on Antiphospholipid Antibodies-Reference-Cited by-同舟云学术

International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: Report from the 13th International Congress on Antiphospholipid Antibodies

Published:2011-12-29 Issue:1 Volume:64 Page:1-10
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Lakos Gabriella,Favaloro Emmanuel J.,Harris E. Nigel,Meroni Pier Luigi,Tincani Angela,Wong Richard C.,Pierangeli Silvia S.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference71 articles.

1. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS);Miyakis;J Thromb Haemost,2006

2. A protocol for determination of anticardiolipin antibodies by ELISA;Pierangeli;Nat Protoc,2008

3. Consensus guidelines on anti-cardiolipin antibody testing and reporting;Wong;Pathology,2004

4. Consensus guidelines on anti-β2 glycoprotein I testing and reporting;Wong;Pathology,2008

5. Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing;Wong;Semin Thromb Hemost,2005

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative assessment of the diagnostic performances of particle-based multianalyte technology and commercial ELISA for antiphospholipid autoantibody testing;Clinica Chimica Acta;2024-08

2. Guidelines on the investigation and management of antiphospholipid syndrome;British Journal of Haematology;2024-07-19

3. IgA Anti-β2-Glycoprotein I Antibodies as Markers of Thrombosis and Severity in COVID-19 Patients;Viruses;2024-07-03

4. Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: A literature review;Autoimmunity Reviews;2024-06

5. Determination of the 99th percentile of anticardiolipin and anti-β2 glycoprotein I antibodies in an institution in the city of Medellin, Colombia;Revista Colombiana de Reumatología (English Edition);2024-01